ZVRA
Zevra Therapeutics Inc.
11.30$
-0.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | -279.3% | – | – | – | |
| – | +8.7% | +9.9% | +12.4% | +108.3% | +92.0% | -3.6% | -6.2% | -10.2% | -5.9% | +267.3% | +6.6% | +535.1% | -36.5% | |
| – | -71.4% | +59.5% | +1,008.3% | +178.6% | -30.9% | +42.4% | -32.1% | -43.5% | -2.2% | +76.3% | +38.7% | +150.4% | -15.2% | |
| – | – | – | – | – | – | – | – | +105.5% | +140.7% | +18.0% | – | – | – | |
| – | – | +1,094.4% | -94.0% | +3,716.1% | -149.7% | – | – | – | -195.5% | – | – | -212.9% | – | |
| – | +169.2% | -4.5% | +177.1% | +376.3% | -71.9% | -88.4% | +23.8% | +26.9% | +209.1% | -8.8% | +218.3% | -100.0% | – | |
| – | -100.7% | +28.6% | +43,668.7% | +145.3% | – | +21.6% | -90.3% | -101.0% | +46,942.4% | +136.5% | -52.6% | +27.4% | – | |
| – | – | – | – | – | – | – | – | – | – | -98.9% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | +67.8% | -27.0% | -100.0% | – | |
| – | – | – | – | – | – | – | – | – | -6,976.7% | – | +95.2% | -34.6% | -100.0% | |
| – | +893.9% | +507.3% | +167.2% | -0.5% | -100.3% | – | -82.4% | -44.5% | +4,029.6% | -92.6% | +240.8% | +188.5% | -85.3% | |
| – | -122.5% | – | +166.3% | -170.5% | – | – | -317.7% | – | +13,984.0% | -143.4% | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | -282.0% | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.